In a proof-of-concept study, [177Lu]Lu-DOTA-folate was applied to NF9006 tumor-bearing mice to investigate whether this radiation stimulus would have an impact on the efficacy of anti-CTLA-4 immunotherapy. This evidence concerns the gene CTLA4 and neoplasm.